Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: The EUCATAX trial
✍ Scribed by Alfredo E. Rodriguez; Cesar F. Vigo; Alejandro Delacasa; Juan Mieres; Carlos Fernandez-Pereira; Victor Bernardi; Marcelo Bettinoti; Alfredo M. Rodriguez-Granillo; Gaston Rodriguez-Granillo; Omar Santaera; Valeria Curotto; Bibiana Rubilar; Jorge Tronge; Igor F. Palacios; David Antoniucci; on behalf of EUCATAX Investigators
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 211 KB
- Volume
- 77
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Objectives: The purpose of the present study was to evaluate the efficacy and safety of a biodegradable polymer coated, paclitaxel eluting stent (Luc‐Chopin^2^) based on 9‐months angiographic and 12‐months clinical follow‐up results. Background: First‐generation drug‐eluting stents util
## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this double‐blind,